CD14 and inflammatory bowel disease: A proof of concept was provided by experiments conducted in 1995 by Grimm et al. showing that radiolabelled-circulating monocytes, isolated from IBD patients and reinfused into the same individual, were retraced as CD14+ cells in the inflammatory mucosa [32].